ES2159021T3 - Peptidos antibioticos procedentes de leche bovina. - Google Patents

Peptidos antibioticos procedentes de leche bovina.

Info

Publication number
ES2159021T3
ES2159021T3 ES96910013T ES96910013T ES2159021T3 ES 2159021 T3 ES2159021 T3 ES 2159021T3 ES 96910013 T ES96910013 T ES 96910013T ES 96910013 T ES96910013 T ES 96910013T ES 2159021 T3 ES2159021 T3 ES 2159021T3
Authority
ES
Spain
Prior art keywords
amino acid
bovine milk
antibiotic peptides
waste
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96910013T
Other languages
English (en)
Inventor
Wolf-Georg Forssmann
Hans-Dieter N-Sachs Inst Zucht
Manfred Raida
Knut Niedersachs Inst Adermann
Hans-Jurgen N-Sachs Ins Magert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharis Biotec GmbH
Original Assignee
Pharis Biotec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharis Biotec GmbH filed Critical Pharis Biotec GmbH
Application granted granted Critical
Publication of ES2159021T3 publication Critical patent/ES2159021T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN PEPTIDO QUE TIENE LA SECUENCIA AMINOACIDA DE FORMULA (I) H2N - X1 -R - X3 X2 - COOH, DONDE X1 ES CERO, O X1 Y/O X2 SON UN RESIDUO QUE REPRESENTA AL MENOS CINCO RESIDUOS AMINOACIDOS (SIMBOLIZADOS CON EL CODIGO DE AMINOACIDOS DE UNA LETRA), PREFERIBLEMENTE AMINOACIDOS NATURALES, CON LA CONDICION DE QUE X1 Y/O X2 CONTENGAN AL MENOS UN RESIDUO AMINOACIDO BASICO SEGUIDO INMEDIATAMENTE POR UN RESIDUO AMINOACIDO HIDROFOBO, Y X1 Y/O X2 CONTENGAN AL MENOS UN RESIDUO DE GLUTAMINA.
ES96910013T 1996-03-25 1996-03-25 Peptidos antibioticos procedentes de leche bovina. Expired - Lifetime ES2159021T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/001296 WO1997035877A1 (en) 1996-03-25 1996-03-25 Antibiotic peptides from bovine milk

Publications (1)

Publication Number Publication Date
ES2159021T3 true ES2159021T3 (es) 2001-09-16

Family

ID=8166184

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96910013T Expired - Lifetime ES2159021T3 (es) 1996-03-25 1996-03-25 Peptidos antibioticos procedentes de leche bovina.

Country Status (7)

Country Link
EP (1) EP0889902B1 (es)
JP (1) JP2000507941A (es)
AT (1) ATE202363T1 (es)
AU (1) AU5334296A (es)
DE (1) DE69613489T2 (es)
ES (1) ES2159021T3 (es)
WO (1) WO1997035877A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532784A (ja) 2001-12-07 2005-11-04 イーペーエフ ファルマシューティカルス ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の抗菌ボリシンペプチド
FR2901796A1 (fr) * 2006-05-31 2007-12-07 Lab Francais Du Fractionnement Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait
AR101099A1 (es) * 2014-07-16 2016-11-23 Dow Global Technologies Llc Método para el tratamiento de superficies de alimentos con péptidos
CN104672302B (zh) * 2014-12-18 2017-06-13 山东深海生物科技股份有限公司 一种多肽菌素、其制备方法及其应用
CN114149486B (zh) * 2021-05-28 2023-05-12 中国科学院大连化学物理研究所 一种抗菌肽mamp-01及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444753C2 (de) * 1994-12-15 1998-08-06 Forssmann Wolf Georg Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung

Also Published As

Publication number Publication date
DE69613489D1 (de) 2001-07-26
WO1997035877A1 (en) 1997-10-02
DE69613489T2 (de) 2002-04-25
AU5334296A (en) 1997-10-17
JP2000507941A (ja) 2000-06-27
EP0889902A1 (en) 1999-01-13
EP0889902B1 (en) 2001-06-20
ATE202363T1 (de) 2001-07-15

Similar Documents

Publication Publication Date Title
ATE201696T1 (de) Zyklische peptidanaloga von somatostatin
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
DE69434817D1 (de) Protease varianten
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES2564463T3 (es) Péptidos antigénicos de Neisseriales
DK0847278T3 (da) Parathyroideahormon-analoger
HUP9904596A1 (hu) Mellékpajzsmirigy-hormon analógok
AU1550297A (en) Amino acid-enriched plant protein reserves, particularly lysine-enriched maize gamma-zein, and plants expressing such proteins
ATE360696T1 (de) Interferon-ähnliches protein zcyto21
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
NO971621L (no) Keratinocyttvekstfaktoranaloger
ES2159021T3 (es) Peptidos antibioticos procedentes de leche bovina.
EP0498784A3 (en) Inhibitors of retroviral protease
CO4700528A1 (es) Peptidos de somatostatina
BR9506038A (pt) Dna clonato vetor recombinante e planta
NO20012232L (no) Enzymatisk amidering av peptider
PE20000759A1 (es) Gen de la citocroma oxidasa de hidroquinona del tipo bd
ATE214731T1 (de) Neuartige protease
PT97783A (pt) Metodo para a preparacao da enzima peptidial-hidroxiglicina n-c liase e do dna que a codifica
NZ241280A (en) Recombinant iga protease with a modified non-functional c-terminal protein sequence
DE3883649D1 (de) Therapeutische Analoga von Somatostatin.
CO5090903A1 (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
ES2158235T3 (es) Peptidos antigenicos con substituciones de glicina.
AR247473A1 (es) Una composicion que produce una respuesta lactogenica o crecimiento en ganado bovino, excluidas todas sus aplicaciones terapeuticas

Legal Events

Date Code Title Description
FC2A Grant refused

Effective date: 19970310

FG2A Definitive protection

Ref document number: 889902

Country of ref document: ES